| Website | transcendmedical.com |
| Category | BioTech |
| Phone | 650-325-2050 |
| Employees | |
| Description | Medical Device Developer |
| Total | $44.4M |
| Series A, 6/09 Morgenthaler Ventures Split Rock Partners Versant Ventures | $9.4M |
| Series B, 6/09 HLM Venture Partners Canaan Partners Latterell Venture Partners Split Rock Partners Technology Partners Morgenthaler Ventures | $35M |
Transcend Medical is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020. The Transcend Medical approach is focused on replacing the current therapies for the treatment of glaucoma with a less invasive procedure and minimal complications.
